July 18, 2025

Blood Test Predicts Organ Aging and Mortality

Researchers used blood proteins to estimate the biological age of 11 organs in over 44,000 people, revealing that older brain and immune systems were linked to higher disease and death risks, while younger ones predicted longer life.

Conexiant

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 14, 2025

GLP-1 Use Tied to Reflux Complications

Researchers found that GLP-1 receptor agonists were associated with an increased risk of GERD and related complications in patients with type 2 diabetes.

Conexiant

July 14, 2025

Potential Links Between Infection and Alzheimer’s Disease

Researchers examine the potential contribution of Chlamydia pneumoniae and SARS-CoV-2 infections to Alzheimer’s disease pathogenesis, focusing on neuroinflammatory mechanisms and genetic factors such as APOEε4.

Conexiant

July 10, 2025

Apheresis Shows Promise for Removing Microplastics From Human Blood

Extracorporeal therapeutic apheresis demonstrated the ability to remove microplastic-like particles from human blood in patients with myalgic encephalomyelitis/chronic fatigue syndrome, according to a study published in Brain Medicine.

Conexiant

July 09, 2025

Recombinant Zoster Vaccine Linked to New-Onset Lupus

Researchers report the first documented case of systemic lupus erythematosus following Shingrix vaccination.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant